Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
LORMETAZEPAM
B & S Healthcare
N05CD06
LORMETAZEPAM
1 Milligram
Tablets
Product subject to prescription which may not be renewed (A)
Benzodiazepine derivatives
Authorised
2011-07-08
NOCTAMID ® 1MG TABLETS (lormetazepam) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. The name of your medicine is Noctamid 1mg tablets but will be referred to as Noctamid throughout this leaflet. WHAT IS IN THIS LEAFLET: 1. WHAT NOCTAMID IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE NOCTAMID 3. HOW TO TAKE NOCTAMID 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE NOCTAMID 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT NOCTAMID IS AND WHAT IT IS USED FOR Noctamid contains lormetazepam, which belongs to the group of medicines called benzodiazepines. Noctamid helps to shorten the time it takes for you to fall asleep reduce the frequency of awakening in the night prolong your sleep time without making you feel tired or drowsy the next day. Your doctor will prescribe Noctamid for a short time only when your sleep problems are severe, disabling or causing extreme distress. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE NOCTAMID DO NOT TAKE NOCTAMID: if you have a particular condition in which the MUSCLES BECOME WEAK and tire easily (myasthenia gravis) if you have severe BREATHING DIFFICULTY (respiratory insufficiency e.g. severe chronic obstruct Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Noctamid 1 mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains lormetazepam 1mg Excipient: Contains lactose For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Tablet _Product imported from Spain:_ Round, white, flat tablets with a beveled edge, imprinted ‘CF’ in a regular hexagon on one face and a breakline on the reverse. The tablet can be divided into equal halves. 4 CLINICAL PARTICULARS As per PA1410/009/001. 5 PHARMACOLOGICAL PROPERTIES As per PA1410/009/001. 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Lactose Maize starch Povidone Magnesium stearate 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf-life expiry date of this product shall be the date shown on the blister and outer package of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25°C. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 07/12/2015_ _CRN 2169742_ _page number: 1_ 6.5 NATURE AND CONTENTS OF CONTAINER 3 blister strips, each containing 10 tablets, presented in an over-labelled cardboard carton. Pack size: 30 tablets 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCT AND OTHER HANDLING OF THE PRODUCT No special requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER B&S Healthcare Unit 4 Bradfield Road Ruislip Middlesex HA4 0NU UK 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA1328/158/001 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 8th July 2011 10 DATE OF REVISION OF THE TEXT December 2015 HEALTH PRODUCTS REGULATORY AUTHORITY ___________ Read the complete document